0001415889-24-012151.txt : 20240503 0001415889-24-012151.hdr.sgml : 20240503 20240503161027 ACCESSION NUMBER: 0001415889-24-012151 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240501 FILED AS OF DATE: 20240503 DATE AS OF CHANGE: 20240503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Luptakova Katarina CENTRAL INDEX KEY: 0001991149 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40925 FILM NUMBER: 24913155 MAIL ADDRESS: STREET 1: C/O XILIO THERAPEUTICS, INC. STREET 2: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xilio Therapeutics, Inc. CENTRAL INDEX KEY: 0001840233 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 851623397 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-833-1027 MAIL ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4-05032024_040506.xml X0508 4 2024-05-01 0001840233 Xilio Therapeutics, Inc. XLO 0001991149 Luptakova Katarina 828 WINTER STREET SUITE 300 WALTHAM MA 02451 false true false false CHIEF MEDICAL OFFICER 0 Stock Option (right to buy) 1.08 2024-05-01 4 A 0 59333 0 A 2034-04-30 Common Stock 59333 59333 D The option award was granted on May 1, 2024 and shall vest on June 1, 2024 with respect to 1/48th of the shares of common stock underlying the stock option and continue to vest in equal monthly installments thereafter until May 1, 2028. /s/ Julia Walcott, Attorney-in-Fact 2024-05-03